BIOMAT Database Logo BIOMAT Database Logo

Evolution of coronary stents in patients with diabetes: are clinical outcomes still improving? 2014

George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Oxford Heart Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

Diabetic patients are prone to diffuse and accelerated atherosclerosis, which increases the likelihood of requiring myocardial revascularization. Diabetes mellitus is a strong risk factor for restenosis following coronary stenting, with greater need for repeat revascularization and inferior clinical outcomes. Despite the recent advances in drug-eluting stent technology, diabetic patients are still at higher risk of adverse clinical events after coronary angioplasty. The focus of this review is to describe the evolution of the percutaneous management of diabetic patients with coronary artery disease and to define if any real progress has been made in terms of safety and efficacy with the use of the second generation drug-eluting stents in this high-risk population.

UI MeSH Term Description Entries
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017130 Angioplasty Reconstruction or repair of a blood vessel, which includes the widening of a pathological narrowing of an artery or vein by the removal of atheromatous plaque material and/or the endothelial lining as well, or by dilatation (BALLOON ANGIOPLASTY) to compress an ATHEROMA. Except for ENDARTERECTOMY, usually these procedures are performed via catheterization as minimally invasive ENDOVASCULAR PROCEDURES. Angioplasty, Transluminal,Endoluminal Repair,Percutaneous Transluminal Angioplasty,Angioplasties,Angioplasty, Percutaneous Transluminal,Endoluminal Repairs,Repair, Endoluminal,Repairs, Endoluminal,Transluminal Angioplasty,Transluminal Angioplasty, Percutaneous
D048909 Diabetes Complications Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE. Complications of Diabetes Mellitus,Diabetes-Related Complications,Diabetic Complications,Diabetes Complication,Diabetes Mellitus Complication,Diabetes Mellitus Complications,Diabetes Related Complications,Diabetes-Related Complication,Diabetic Complication
D054855 Drug-Eluting Stents Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu. Drug-Coated Stent,Drug-Coated Stents,Drug-Eluting Stent,Stents, Drug-Coated,Stents, Drug-Eluting,Drug Coated Stent,Drug Coated Stents,Drug Eluting Stent,Drug Eluting Stents,Stent, Drug-Coated,Stent, Drug-Eluting,Stents, Drug Coated,Stents, Drug Eluting
D023903 Coronary Restenosis Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction. Coronary Restenoses,Restenoses, Coronary,Restenosis, Coronary

Related Publications

George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Improving long-term outcomes of coronary intervention in patients with diabetes.
March 2009, Chinese medical journal,
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Why are we still using coronary bare-metal stents?
March 2013, Journal of the American College of Cardiology,
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology.
January 2018, Interventional cardiology (London, England),
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Clinical outcomes of silicon carbide coated stents in patients with coronary artery disease.
February 2002, Medical science monitor : international medical journal of experimental and clinical research,
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients.
June 2006, The Journal of invasive cardiology,
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Hyperexpansion of coronary stents and clinical outcomes.
January 2006, Texas Heart Institute journal,
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Improving Outcomes in Patients With Diabetes Mellitus.
February 2019, Journal of the American Heart Association,
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Future strategies for improving outcomes in patients with diabetes and acute coronary syndromes.
March 2007, Future cardiology,
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
Are outcomes improving in patients with ARDS?
December 2009, American journal of respiratory and critical care medicine,
George Kassimis, and Giovanni Luigi De Maria, and Niket Patel, and Adrian P Banning
One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents.
September 2008, Circulation journal : official journal of the Japanese Circulation Society,
Copied contents to your clipboard!